ASCO Indivumed Launches Bioinformatics Platform, Expands Cancer Drug Discovery Efforts Premium The firm has revamped its business model to focus on AI-driven drug discovery and partnerships with pharma and academic cancer researchers. Molecular Profiling in Pediatric Cancer Trials Continues to Prove Valuable for Treatment Matching Premium The GAIN/iCat2 study and the Pediatric MATCH trial showed that molecular data has a significant impact on treatment recommendations for kids with cancer. Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications Research presented at the ASCO meeting described efforts to expand the use of existing technologies into new directions. New Liquid Biopsy Data at ASCO Highlights Commercial Push Into Early Cancer Detection Cancer diagnostic firms showcased their discoveries as they flesh out their DNA methylation- and fragmentation-based platforms using circulating tumor DNA. Liquid Biopsy-Guided EGFR Rechallenge Therapy Shows Benefit for Colorectal Cancer Patients The first interventional trial to use ctDNA to recruit eligible patients for this treatment showed 30 percent observable responses and more than 60 percent disease control. Jun 8, 2021 ASCO Studies Highlight Systemic, Racial Inequities in Lung Cancer Biomarker Testing Premium Jun 7, 2021 Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance Premium Jun 7, 2021 Lynparza Benefit in Early BRCA-Mutated Breast Cancer Reignites Universal Genetic Testing Discussion Premium Jun 5, 2021 Myriad Genetics Recalibrates Breast Cancer PRS for All Ancestries in Anticipation of Broader Launch Premium Jun 4, 2021 Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data Premium Jun 4, 2021 Veracyte Expects HalioDx Acquisition to Drive International Market Growth Premium Dec 3, 2020 Jackson Laboratory Coordinating Clinical Trial Sites for ASCO's TAPUR Trial Jun 29, 2020 Creatv MicroTech Aims to Detect Patient Immune Cells for Cancer Drug Response Prediction Premium Jun 12, 2020 New Data Support Role of Agendia BluePrint Test in Refining Breast Cancer Subtypes Premium Jun 4, 2020 Tumor Mutational Burden in Blood May Predict Immunotherapy Response in Head, Neck Cancer Jun 2, 2020 Evidence for Targeted Treatment Builds in Cancers of Unknown Primary but Randomized Data Pending Premium Jun 2, 2020 Tiziana Life Sciences to Launch Spinoff to Market Breast Cancer Recurrence Assay in Europe Premium May 31, 2020 Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients May 31, 2020 Oncotype DX May Be Helpful in Guiding Neoadjuvant Breast Cancer Treatment Decisions Premium May 31, 2020 Polygenic Risk Score, Family History Refine Breast Cancer Risk Assessment in CHEK2 Mutation Carriers May 30, 2020 Pediatric Precision Oncology Study Matches 28 Percent of Patients to Targeted Therapies May 29, 2020 Lucence Dx Liquid Biopsy Tech Detects Structural Rearrangements, Breast Cancer Mutations Premium May 29, 2020 Patients Having Ovaries Removed Without Clear Genetic, Medical Rationale, Study Suggests Premium May 18, 2020 Roche's Flatiron Health, Foundation Medicine, Genentech Launch Clinico-Genomic Lung Cancer Study Feb 19, 2020 Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing Load More Breaking News IV BioHoldings Partners With P4 Diagnostix, Unveils 'Bio Innovation Studio' Polynesian Island Population History Revealed From Present-Day Human Genomes Aviv Scientific Closes $40M Series B Financing Round Roche Nabs CE Mark for Three Cobas Respiratory Test Panels Hexagon Bio Raises $61M in Private Financing Round GenXys, Helix Partner to Provide Clinical Decision Support for PGx Testing The Scan Not Yet a Permanent One NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials. Unfair Targeting Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases. Limited Rapid Testing The New York Times wonders why rapid tests for COVID-19 are not widely available in the US. Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.